 Mutant APC molecules that lack anticoagulant activity and the associated bleedingcomplications are expected to improve patient survival Bolus dosing of the drug offers more simplified use Exclusively licensed in 2010
[Detail]
- Achieve significantly better translation quality measured by the BLEU score- Improves readability of the translation
[Detail]
Handles higher crowd densities Requires only still images
[Detail]
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] | -> >| |